TaiMed Biologics Inc. (TPEX:4147)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
81.80
+0.30 (0.37%)
Jun 6, 2025, 1:30 PM CST

TaiMed Biologics Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
22,34123,48520,74617,84317,81321,212
Upgrade
Market Cap Growth
8.55%13.20%16.27%0.17%-16.02%-15.12%
Upgrade
Enterprise Value
21,18121,84220,85917,86017,48720,408
Upgrade
Last Close Price
81.8086.0080.8369.6969.5982.90
Upgrade
Forward PE
--282.76--87.60
Upgrade
PS Ratio
36.7838.4942.1931.6943.0929.36
Upgrade
PB Ratio
5.585.848.096.576.066.21
Upgrade
P/TBV Ratio
6.406.7410.698.968.408.57
Upgrade
EV/Sales Ratio
34.8735.8042.4231.7242.3028.25
Upgrade
EV/EBITDA Ratio
-----8869.02
Upgrade
Debt / Equity Ratio
0.130.130.290.280.190.17
Upgrade
Debt / EBITDA Ratio
-----130.59
Upgrade
Asset Turnover
0.120.140.120.130.080.15
Upgrade
Inventory Turnover
0.270.280.200.270.270.29
Upgrade
Quick Ratio
13.0113.262.312.325.123.23
Upgrade
Current Ratio
24.1225.185.966.5610.376.02
Upgrade
Return on Equity (ROE)
-5.15%-6.13%-7.38%-9.52%-14.82%-5.24%
Upgrade
Return on Assets (ROA)
-2.98%-3.55%-2.60%-2.75%-6.20%-1.67%
Upgrade
Return on Capital (ROIC)
-3.28%-4.01%-3.06%-3.43%-8.11%-2.18%
Upgrade
Earnings Yield
-0.95%-0.86%-0.94%-1.51%-2.64%-0.86%
Upgrade
FCF Yield
-1.67%-1.65%-0.15%-3.41%-1.24%-1.21%
Upgrade
Buyback Yield / Dilution
-7.93%-6.08%-0.18%-0.04%-0.03%-0.07%
Upgrade
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.